NCT01895400View on ClinicalTrials.gov

Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy

PHASE3TerminatedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Recurrent Vestibulopathy
Interventions
DRUG

Renexin (cilostazol 100mg + gingko biloba extract 80 mg)

Take Renexin 1T bid po medication for 8 weeks

DRUG

Placebo

Take placebo drug 1T bid po medication for 8 weeks

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors

Collaborators (1)

Asan Medical Center
All Listed Sponsors
collaborator

SK Chemicals Co., Ltd.

INDUSTRY

collaborator

Asan Medical Center

OTHER

lead

Jong Woo Chung

OTHER

NCT01895400 - Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy | Biotech Hunter | Biotech Hunter